National Institute for Korean Medicine Development and Korea Health Industry Development Institute Join Hands for the Scientific Advancement of Korean Medicine

by Gu Daeseon

Published 07 Sep.2023 17:24(KST)

Updated 06 Aug.2025 14:04(KST)

open/close

The National Institute for Korean Medicine Development (Director Jung Changhyun) announced on September 7 that it had signed a business agreement with the Korea Health Industry Development Institute (Director Cha Sundo) to promote the scientific advancement of Korean medicine and to facilitate the utilization and dissemination of research outcomes.

Under this agreement, the two institutions will establish an active cooperation system that includes jointly identifying and carrying out research projects and collaborative initiatives, exchanging human resources through training programs for the development of professional talent, providing technical support and expanding the utilization of research outcomes for research and development project management, and cooperating to promote the overseas expansion of medical services-including Korean medicine-and attract foreign patients.

Jung Changhyun, director of the National Institute for Korean Medicine Development (right), and Cha Sundo, director of the Korea Health Industry Development Institute, are signing a business agreement to promote the scientific advancement of Korean medicine.

Jung Changhyun, Director of the National Institute for Korean Medicine Development, stated, “Going forward, both institutions will establish a close cooperative framework and actively leverage our respective strengths to accelerate research and development for the scientific advancement of Korean medicine. I hope this agreement will serve as a catalyst for further growth in the Korean medicine industry.”

Cha Sundo, Director of the Korea Health Industry Development Institute, also commented, “With this business agreement, a practical foundation for cooperation between the two institutions has been established. We will do our utmost to strengthen the support system for the scientific advancement and industrialization of Korean medicine, foster evidence-based Korean medicine, and enhance the quality of Korean medicine services.”